Cervical cancer is one of the widespread cancers in girls accounting for 7.9% of all cancers. In India it’s the second commonest cancer in girls. The immortality of the cancer cell and the comparatively lengthy timeframe from acquisition of an infection to growth of cervical cancer was established.
As main developments like LBC, HPV testing have been launched within the current years, screening has taken a brand new avatar, the Molecular pap!! The goals of this research have been: To evaluate gynecologic cytology and irregular outcomes with respect to standard and LBC. To research the function of HPV cotesting and ancillary checks carried out, that’s, HPV CISH, and p16ink4a by IHC.
About 71 924 Conventional and LBC samples have been included from August 2009 to December 2017. Cases for HPV testing alongside the traditional smears have been 1539. HPV could be examined from the identical LBC vial because the pattern stays steady at room temperature for six weeks. HPV DNA PCR was carried out in our laboratory for High and Low danger genotypes.
Cytology findings have been additionally correlated with histology. Detection charge of SILs in LBC samples have been greater (2.20%). The commonest abnormality was LSIL in LBC and ASCUS in typical smears. LBC with HPV cotesting improves sensitivity and specificity and reduces ambiguous outcomes; permits higher compliance, as a adverse outcome of each checks permits sufferers to get screening each 5 years, thereby rising screening intervals, essential in a useful resource restricted state of affairs.
Touch imprint (TI) cytology of needle core biopsies (NCB) in pathology laboratories: A observe survey of contributors within the College of American Pathologists (CAP) Non Gynecologic Cytopathology (NGC) Education Program.
Intra-procedural evaluation of contact imprint (TI) cytology from needle core biopsies (NCB) is used to make sure pattern adequacy and to offer rapid prognosis in numerous settings. We aimed to survey laboratories for present practices on the use of cytology with NCB. A voluntary supplemental questionnaire together with questions on demographics, personnel concerned, websites, accessioning, and reporting was despatched with the College of American Pathologists (CAP) 2015 Non gynecologic Cytopathology Education Program to survey practices of cytologic evaluation of NCB.
Among 844 respondents, 403 (48%) carried out cytologic evaluation of NCB. Common physique websites included lung (94%; 368/392), liver (87%; 340/ 392), and lymph nodes/spleen (77%; 303/392). Most of the time, a pathologist was current on-site 75% (295/393) for adequacy evaluation which was often verbally reported to the supplier performing the process.
Specimens have been ready by cytotechnologists (50%; 193 of 388) or pathologists (45%; 176 of 388) by touching the core to the slide (50%; 196 of 390) and rolling the core on the slide (45%; 177/390). Among the respondents, 19% stated that cytotechnologists independently carried out rapid evaluation of TI of NCB. Most laboratories (69%; 264/384) evaluated air-dried slides with a modified Giemsa stain and rendered one TI/NCB mixed report (87%, 334/385).
p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient inhabitants.
Women who check optimistic for a high-risk sort of the human papillomavirus (HPV) require triage testing to determine these girls with cervical intraepithelial neoplasia grade Three or cancer (≥CIN3). Although Pap cytology is taken into account a gorgeous triage check, its applicability is hampered by its subjective nature. This research prospectively in contrast the scientific efficiency of p16/Ki-67 dual-stained cytology to that of Pap cytology, with or with out HPV16/18 genotyping, in high-risk HPV-positive girls visiting gynecologic outpatient clinics (n=446 and age 18-66 years).
From all girls, cervical scrapes (for Pap cytology, HPV16/18 genotyping, and p16/Ki-67 dual-stained cytology) and colposcopy-directed biopsies have been obtained. This is the primary survey carried out particularly to find out the observe of adequacy evaluation of TI of NCB. Cytotechnologists are usually not performing adequacy evaluation of TI with out pathologist oversight. A single report is often issued which incorporates the adequacy evaluation as a component of the ultimate report.
The sensitivity of p16/Ki-67 dual-stained cytology for ≥CIN3 (93.8%) did neither differ considerably from that of Pap cytology (87.7%; ratio 1.07 and 95% confidence interval (CI): 0.97-1.18) nor from that of Pap cytology mixed with HPV16/18 genotyping (95.1%; ratio 0.99 and 95% CI: 0.91-1.07). However, the specificity of p16/Ki-67 dual-stained cytology for ≥CIN3 (51.2%) was considerably greater than that of Pap cytology (44.9%; ratio 1.14 and 95% CI: 1.01-1.29) and Pap cytology mixed with HPV16/18 genotyping (25.8%; ratio 1.99 and 95% CI: 1.68-2.35).
After exclusion of girls who had been referred as a result of of irregular Pap cytology, the specificity of p16/Ki-67 dual-stained cytology for ≥CIN3 (56.7%) remained the identical, whereas that of Pap cytology (60.3%) elevated considerably, leading to the same specificity of each assays (ratio 0.94 and 95% CI: 0.83-1.07) on this sub-cohort. In abstract, p16/Ki-67 dual-stained cytology has a superb scientific efficiency and is an fascinating goal microscopy-based triage device for high-risk HPV-positive girls.
Gill’s Hematoxylin #2, double strength for Histology & Cytology |
24243-500 |
Polysciences Europe GmbH |
500ml |
EUR 65 |
Description: 7732-18-5 |
Viral Transport Medium |
IGVTM1000ML |
Innovative research |
each |
EUR 317 |
|
Description: Viral Transport Medium |
Viral Transport Medium |
IGVTM500ML |
Innovative research |
each |
EUR 168 |
|
Description: Viral Transport Medium |
Viral Transport Medium Liquid Amies |
IGVTMA1000ML |
Innovative research |
each |
EUR 145 |
|
Description: Viral Transport Medium Liquid Amies |
Viral Transport Medium Liquid Amies |
IGVTMA500ML |
Innovative research |
each |
EUR 81 |
|
Description: Viral Transport Medium Liquid Amies |
Viral Transport Medium Veal Infusion |
IGVTMV1000ML |
Innovative research |
each |
EUR 141 |
|
Description: Viral Transport Medium Veal Infusion |
Viral Transport Medium Veal Infusion |
IGVTMV500ML |
Innovative research |
each |
EUR 81 |
|
Description: Viral Transport Medium Veal Infusion |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
20-abx147914 |
Abbexa |
|
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
abx330898-100ul |
Abbexa |
100 ul |
EUR 510 |
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
20-abx327220 |
Abbexa |
|
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
abx027854-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
abx027854-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
20-abx015115 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
-
EUR 84.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
- 5 ug
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
20-abx311414 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (HRP) |
20-abx311415 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (FITC) |
20-abx311416 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (Biotin) |
20-abx311417 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cnnm4 (untagged) - Rat cyclin and CBS domain divalent metal cation transport mediator 4 (Cnnm4) |
RN217195 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Cnnm4 (myc-DDK-tagged) - Rat cyclin and CBS domain divalent metal cation transport mediator 4 (Cnnm4) |
RR217195 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Transport Canister |
M-CBP-PTC1 |
MiTeGen |
1 UNIT |
EUR 500 |
Description: Transport Canister |
Sample Transport Reagent |
SSFIN-0007 |
Zeptometrix |
20mL |
EUR 32 |
Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (100 x 1 ml vials) |
BSV-VTM-003 |
BioServUK |
100 x 1 ml |
Ask for price |
Description: Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (100 x 1 ml vials) |
Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (500 x 1 ml vials) |
BSV-VTM-004 |
BioServUK |
500 x 1 ml |
Ask for price |
Description: Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (500 x 1 ml vials) |
Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (100 x 3 ml vials) |
BSV-VTM-005 |
BioServUK |
100 x 3 ml |
Ask for price |
Description: Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (100 x 3 ml vials) |
Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (500 x 3 ml vials) |
BSV-VTM-006 |
BioServUK |
500 x 3 ml |
Ask for price |
Description: Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (500 x 3 ml vials) |
Sterile Viral Transport and Preservation Medium; Conical Bottom Tube (100 x 3 ml vials) |
BSV-VTM-001 |
BioServUK |
100 x 3 ml |
Ask for price |
Description: Sterile Viral Transport and Preservation Medium; Conical Bottom Tube (100 x 3 ml vials) |
Sterile Viral Transport and Preservation Medium; Conical Bottom Tube (500 x 3 ml vials) |
BSV-VTM-002 |
BioServUK |
500 x 3 ml |
Ask for price |
Description: Sterile Viral Transport and Preservation Medium; Conical Bottom Tube (500 x 3 ml vials) |
Sterile 5mL Transport Tube (Axygen) |
TUBE5AX-S2 |
Next Advance |
500box |
EUR 267.6 |
Description: Skirted screw-cap 5mL Axygen tubes with caps. Sterile, RNase & DNase free. |
Golgi Transport 1A (GOLT1A) Antibody |
20-abx215662 |
Abbexa |
|
|
|
Golgi Transport 1A (GOLT1A) Antibody |
20-abx325291 |
Abbexa |
|
|
|
Nuclear Transport Factor 2 Protein |
20-abx260609 |
Abbexa |
-
EUR 3433.20
-
EUR 393.60
-
EUR 276.00
|
|
|
Copper Transport Protein ATOX1 Protein |
20-abx260559 |
Abbexa |
-
EUR 3433.20
-
EUR 393.60
-
EUR 276.00
|
|
|
Intraflagellar Transport 74 (IFT74) Antibody |
20-abx211358 |
Abbexa |
|
|
|
Intraflagellar Transport 22 (IFT22) Antibody |
20-abx323090 |
Abbexa |
|
|
|
Intraflagellar Transport 74 (IFT74) Antibody |
20-abx339906 |
Abbexa |
|
|
|
Intraflagellar Transport 74 (IFT74) Antibody |
abx433491-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
Intraflagellar Transport 74 (IFT74) Antibody |
abx430131-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
Intraflagellar Transport 22 (IFT22) Antibody |
20-abx301658 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Intraflagellar Transport 20 Homolog Protein |
20-abx260949 |
Abbexa |
-
EUR 4101.60
-
EUR 393.60
-
EUR 276.00
|
|
|
Human Nuclear transport factor 2 (NUTF2) |
1-CSB-EP016214HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Nuclear transport factor 2(NUTF2) expressed in E.coli |
Non-Sterile 5mL Transport Tube (Axygen) |
TUBE5AX |
Next Advance |
1000box |
EUR 256.8 |
Description: Skirted screw-cap 5mL Axygen tubes with caps. Non-sterile. |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC942144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF594 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC942144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF594 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC802144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF680 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC802144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF680 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC702144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF770 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC702144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF770 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC882144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF488A conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC882144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF488A conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC812144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF680R conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC812144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF680R conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC052144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF405M conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC052144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF405M conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC042144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF405S conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC042144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF405S conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC402144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF640R conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC402144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF640R conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNCAP2144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNCAP2144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNCA2144-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), APC conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNCP2144-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), PerCP conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNCR2144-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), RPE conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNCH2144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNCH2144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNCB2144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), Biotin conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNCB2144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), Biotin conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNUB2144-100 |
Biotium |
100uL |
EUR 316.8 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), Concentration: 0.2mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNUB2144-50 |
Biotium |
50uL |
EUR 486 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), 1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNUB2144-500 |
Biotium |
500uL |
EUR 615.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), Concentration: 0.2mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC472144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF647 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC472144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF647 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC552144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF555 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC552144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF555 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC612144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF660R conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC612144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF660R conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC432144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF543 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC432144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF543 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC682144-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF568 conjugate, Concentration: 0.1mg/mL |
Albumin (Transport Protein) (ALB/2144) Antibody |
BNC682144-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Albumin (Transport Protein) (ALB/2144), CF568 conjugate, Concentration: 0.1mg/mL |
Human Tricarboxylate transport protein (SLC20A3) |
1-CSB-RP049544h |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Tricarboxylate transport protein(SLC20A3),partial expressed in E.coli |
Nuclear Transport Factor 2 (NUTF2) Antibody |
20-abx114209 |
Abbexa |
|
|
|
Nuclear Transport Factor 2 (NUTF2) Antibody |
20-abx131393 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1446.00
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Nuclear Transport Factor 2 (NUTF2) Antibody |
20-abx328651 |
Abbexa |
|
|
|
Nuclear Transport Factor 2 (NUTF2) Antibody |
20-abx320705 |
Abbexa |
|
|
|
Nuclear Transport Factor 2 (NUTF2) Antibody |
20-abx005341 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Albumin (Transport Protein)(ALB/2141), 0.2mg/mL |
BNUB2141-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Albumin (Transport Protein)(ALB/2141), 0.2mg/mL |
BNUB2141-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Albumin (Transport Protein)(ALB/2142), 0.2mg/mL |
BNUB2142-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Albumin (Transport Protein)(ALB/2142), 0.2mg/mL |
BNUB2142-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Albumin (Transport Protein)(ALB/2355), 0.2mg/mL |
BNUB2355-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Albumin (Transport Protein)(ALB/2355), 0.2mg/mL |
BNUB2355-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Albumin (Transport Protein)(ALB/2356), 0.2mg/mL |
BNUB2356-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Albumin (Transport Protein)(ALB/2356), 0.2mg/mL |
BNUB2356-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Albumin (Transport Protein)(ALB/2141), 1mg/mL |
BNUM2141-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Every gynecologic cytology specimen examined by each a CT and a CP from December 2004 to March 2015 was extracted from the laboratory info system; glandular interpretations have been excluded. Excel and SAS have been used for CT-CP pair evaluation. CT-CP pairs with fewer than 32 specimens (the bottom quartile) have been excluded. For the remaining CT-CP pairs, 30 specimens or 10% of the specimens (whichever was greater) have been randomly chosen for comparability by a weighted κ statistic. κ values larger than 0.6 represented good settlement inside CT-CP pairs.